Sobolewska Joanna, Respondek Wioleta, Witek Przemyslaw
Department of Internal Medicine, Endocrinology and Diabetes, Medical University of Warsaw, Warsaw, Poland.
Department of Internal Medicine, Endocrinology and Diabetes, Mazovian Brodnowski Hospital, Warsaw, Poland.
Front Endocrinol (Lausanne). 2025 Feb 11;16:1533711. doi: 10.3389/fendo.2025.1533711. eCollection 2025.
The primary management in the care of patients with adrenal incidentalomas is to determine the oncologic risk, namely, the possibility of malignancy. The first place among adrenal incidentaloma lesions requiring diagnosis and treatment promptly is adrenocortical carcinoma (ACC). Similarly, in the case of pheochromocytoma, the lack of early diagnosis worsens the patient's prognosis. Even though both ACC and pheochromocytoma are among the less frequent adrenal lesions, neither should be excluded during differential diagnostics, especially in patients with an equivocal clinical presentation and non-typical adenoma radiological features. ACC presenting as pheochromocytoma is one of the few cases described in the literature, some of which could not collect exhaustive clinical data. Herein, in this article, we would like to provide an overview of reported ACC cases clinically manifesting as pheochromocytoma, based on the clinical image of a 59-year-old female patient with unintentional weight loss, non-specific abdominal pain, a diagnosis of hypertension, and significantly elevated excretion of 3-methoxytyramine in a 24-h urine collection, histopathologically diagnosed with ACC. The case presented emphasizes how crucial a comprehensive diagnostics and individual approach to the patient would be.
肾上腺偶发瘤患者护理的主要管理措施是确定肿瘤风险,即恶性肿瘤的可能性。在需要立即诊断和治疗的肾上腺偶发瘤病变中,肾上腺皮质癌(ACC)位居首位。同样,对于嗜铬细胞瘤,缺乏早期诊断会使患者的预后恶化。尽管ACC和嗜铬细胞瘤都是较少见的肾上腺病变,但在鉴别诊断过程中都不应被排除,尤其是对于临床表现不明确且腺瘤具有非典型放射学特征的患者。表现为嗜铬细胞瘤的ACC是文献中描述的少数病例之一,其中一些病例无法收集详尽的临床数据。在此,我们希望基于一名59岁女性患者的临床影像,对报告的临床表现为嗜铬细胞瘤的ACC病例进行概述。该患者出现体重意外减轻、非特异性腹痛、高血压诊断以及24小时尿样中3-甲氧基酪胺排泄显著升高,经组织病理学诊断为ACC。所呈现的病例强调了全面诊断和针对患者的个体化方法的重要性。